Tweets
In an early SpA (DESIR) cohort, the occurrence of a first pregnancy did not seem to increase the number of imaging abnormalities of the SIJ. Overall no significant changes in radiographic and MRI imaging abnormalities of the SIJ, Molto A, Abst#POS0303, #EULAR2023 @RheumNow
Dr. Antoni Chan @synovialjoints ( View Tweet )
3 years 1 month ago
Supervised 12 weeks High-intensity interval training program
Improves Vo2 peak in IA patients
But does not improve pain or fatigue
It is disappointing but it is also a small study w/ n=30 pts in each group.
It is unclear if the type of exercise has an impact on outcome https://t.co/Plk7sflrh5
Aurelie Najm @AurelieRheumo ( View Tweet )
3 years 1 month ago
What happens when an AI-based symptom checker & an online self-referral tool play Rheumatologists?
They don't seem to do great yet!
600 new pts, outw/ 36% dvlpd IA
IA Sens 62% Spe 47%
Tool Sens 66% Spe 54%
More work needed to implement these in practice
#EULAR23 @Rheumnow
Aurelie Najm @AurelieRheumo ( View Tweet )
3 years 1 month ago
RheumNow’s expanded coverage of the #EULAR2023 meeting is sponsored in part by Bristol Myers Squibb. All content is chosen by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
RheumNow Eular 2023 Daily Recap Series https://t.co/ZJd3mSBcau
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
AOSD: Young vs. Elderly Onset
AOSDis an autoinflammatory condition characterized by fevers, arthritis, and rash. It is considered an orphan disease because of its low prevalence - it is reported anywhere between 16 to 40 per ten million.
https://t.co/PPI1fvwLAf https://t.co/qMXMsbpwl3
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
Top Influencers of #EULAR2023 👉 @eular_org @EMEUNET @RheumNow @ARD_BMJ @drdavidliew @Janetbirdope https://t.co/uUJM6tW824 via @symplur
Alina DIMA @drALINAdima ( View Tweet )
3 years 1 month ago
Wasn’t following the SLE stuff #EULAR2023 but heard a lot of talk about both telitacicept & CAR-T, including meeting highlights by Christian Dejaco.
Both look pretty exciting - the longer the sustained remission with CAR-T, the more it looks like maybe the real deal @RheumNow https://t.co/oKzb8ojTcz
David Liew @drdavidliew ( View Tweet )
3 years 1 month ago
#EULAR2023 Clinical Highlights. Osteoarthritis. OP0071 Single centre Phase 2 RCT showed Denosumab halted erosion in Erosive OA at 24 weeks treatment, and the treatment effect enhances after 48 weeks vs PBO @RheumNow https://t.co/YWFUg3cp7P
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
3 years 1 month ago
Tune it at 1pm EST for RheumNow's daily #EULAR23 recaps. You can find us live on YouTube, Twitter and LinkedIn. https://t.co/i8rm5t8mFS
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
RheumNow’s expanded coverage of the #EULAR2023 annual meeting is sponsored in part by Bristol Myers Squibb. All content is chosen by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
Depositions of crystals in coronary arteries were associated with MACE @rheumnow #EULAR2023 https://t.co/VHxtsB7ZsA
Bella Mehta @bella_mehta ( View Tweet )
3 years 1 month ago
